ImmunoCellular Therapeutics, Ltd. (NYSE MKT: IMUC) announced that Andrew Gengos, Chief Executive Officer, will present a corporate overview and business update at the 18th Annual BIO CEO & Investor Conference at 2:00 pm ET on Monday, February 8, ...
more»